High-phosphate induces Runx2 expression in VSMCs through activating β-catenin.
Two forms of active β-catenin are upregulated in VSMCs treated with high-phosphate.
Two functional TBEs are identified in the promoter region of Runx2 gene in VSMCs.
Targeting WNT/β-catenin signaling may offer therapeutic intervention for AMC.